nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—lung cancer	0.222	0.561	CbGaD
Riluzole—CYP1A1—lung cancer	0.174	0.439	CbGaD
Riluzole—ABCG2—Topotecan—lung cancer	0.0495	0.129	CbGbCtD
Riluzole—ABCG2—Gefitinib—lung cancer	0.0453	0.118	CbGbCtD
Riluzole—ABCG2—Teniposide—lung cancer	0.0439	0.115	CbGbCtD
Riluzole—CYP1A1—Gefitinib—lung cancer	0.0418	0.109	CbGbCtD
Riluzole—ABCG2—Erlotinib—lung cancer	0.0268	0.07	CbGbCtD
Riluzole—CYP1A1—Erlotinib—lung cancer	0.0247	0.0646	CbGbCtD
Riluzole—ABCG2—Paclitaxel—lung cancer	0.0245	0.0641	CbGbCtD
Riluzole—ABCG2—Irinotecan—lung cancer	0.0242	0.0632	CbGbCtD
Riluzole—ABCG2—Cisplatin—lung cancer	0.0197	0.0515	CbGbCtD
Riluzole—ABCG2—Etoposide—lung cancer	0.0194	0.0506	CbGbCtD
Riluzole—ABCG2—Docetaxel—lung cancer	0.0177	0.0463	CbGbCtD
Riluzole—ABCG2—Doxorubicin—lung cancer	0.0132	0.0345	CbGbCtD
Riluzole—ABCG2—Methotrexate—lung cancer	0.0128	0.0334	CbGbCtD
Riluzole—CYP1A2—Erlotinib—lung cancer	0.011	0.0289	CbGbCtD
Riluzole—CYP1A2—Etoposide—lung cancer	0.00799	0.0209	CbGbCtD
Riluzole—Pain—Paclitaxel—lung cancer	3.43e-05	0.00022	CcSEcCtD
Riluzole—Confusional state—Docetaxel—lung cancer	3.43e-05	0.00022	CcSEcCtD
Riluzole—Pharyngitis—Methotrexate—lung cancer	3.43e-05	0.000219	CcSEcCtD
Riluzole—Urinary tract disorder—Methotrexate—lung cancer	3.41e-05	0.000218	CcSEcCtD
Riluzole—Photosensitivity reaction—Doxorubicin—lung cancer	3.41e-05	0.000218	CcSEcCtD
Riluzole—Oedema—Docetaxel—lung cancer	3.4e-05	0.000218	CcSEcCtD
Riluzole—Anaphylactic shock—Docetaxel—lung cancer	3.4e-05	0.000218	CcSEcCtD
Riluzole—Weight increased—Doxorubicin—lung cancer	3.4e-05	0.000217	CcSEcCtD
Riluzole—Pruritus—Gemcitabine—lung cancer	3.39e-05	0.000217	CcSEcCtD
Riluzole—Urethral disorder—Methotrexate—lung cancer	3.39e-05	0.000217	CcSEcCtD
Riluzole—Infection—Docetaxel—lung cancer	3.38e-05	0.000216	CcSEcCtD
Riluzole—Weight decreased—Doxorubicin—lung cancer	3.38e-05	0.000216	CcSEcCtD
Riluzole—Feeling abnormal—Etoposide—lung cancer	3.38e-05	0.000216	CcSEcCtD
Riluzole—Diarrhoea—Irinotecan—lung cancer	3.37e-05	0.000216	CcSEcCtD
Riluzole—Pneumonia—Doxorubicin—lung cancer	3.35e-05	0.000214	CcSEcCtD
Riluzole—Gastrointestinal pain—Etoposide—lung cancer	3.35e-05	0.000214	CcSEcCtD
Riluzole—Shock—Docetaxel—lung cancer	3.35e-05	0.000214	CcSEcCtD
Riluzole—Nervous system disorder—Docetaxel—lung cancer	3.34e-05	0.000214	CcSEcCtD
Riluzole—Thrombocytopenia—Docetaxel—lung cancer	3.33e-05	0.000213	CcSEcCtD
Riluzole—Infestation NOS—Doxorubicin—lung cancer	3.33e-05	0.000213	CcSEcCtD
Riluzole—Infestation—Doxorubicin—lung cancer	3.33e-05	0.000213	CcSEcCtD
Riluzole—Tachycardia—Docetaxel—lung cancer	3.32e-05	0.000213	CcSEcCtD
Riluzole—Feeling abnormal—Paclitaxel—lung cancer	3.31e-05	0.000212	CcSEcCtD
Riluzole—Skin disorder—Docetaxel—lung cancer	3.31e-05	0.000211	CcSEcCtD
Riluzole—Hypersensitivity—Cisplatin—lung cancer	3.29e-05	0.000211	CcSEcCtD
Riluzole—Gastrointestinal pain—Paclitaxel—lung cancer	3.28e-05	0.00021	CcSEcCtD
Riluzole—Diarrhoea—Gemcitabine—lung cancer	3.28e-05	0.00021	CcSEcCtD
Riluzole—Erythema multiforme—Methotrexate—lung cancer	3.27e-05	0.000209	CcSEcCtD
Riluzole—Neuropathy peripheral—Doxorubicin—lung cancer	3.27e-05	0.000209	CcSEcCtD
Riluzole—Dizziness—Irinotecan—lung cancer	3.26e-05	0.000208	CcSEcCtD
Riluzole—Urticaria—Etoposide—lung cancer	3.25e-05	0.000208	CcSEcCtD
Riluzole—Stomatitis—Doxorubicin—lung cancer	3.25e-05	0.000208	CcSEcCtD
Riluzole—Jaundice—Doxorubicin—lung cancer	3.25e-05	0.000208	CcSEcCtD
Riluzole—Anorexia—Docetaxel—lung cancer	3.25e-05	0.000208	CcSEcCtD
Riluzole—Abdominal pain—Etoposide—lung cancer	3.24e-05	0.000207	CcSEcCtD
Riluzole—Body temperature increased—Etoposide—lung cancer	3.24e-05	0.000207	CcSEcCtD
Riluzole—Urinary tract infection—Doxorubicin—lung cancer	3.24e-05	0.000207	CcSEcCtD
Riluzole—Eye disorder—Methotrexate—lung cancer	3.23e-05	0.000206	CcSEcCtD
Riluzole—Asthenia—Cisplatin—lung cancer	3.21e-05	0.000205	CcSEcCtD
Riluzole—Cardiac disorder—Methotrexate—lung cancer	3.21e-05	0.000205	CcSEcCtD
Riluzole—Sweating—Doxorubicin—lung cancer	3.19e-05	0.000204	CcSEcCtD
Riluzole—Urticaria—Paclitaxel—lung cancer	3.19e-05	0.000204	CcSEcCtD
Riluzole—Hypotension—Docetaxel—lung cancer	3.18e-05	0.000203	CcSEcCtD
Riluzole—Haematuria—Doxorubicin—lung cancer	3.18e-05	0.000203	CcSEcCtD
Riluzole—Abdominal pain—Paclitaxel—lung cancer	3.18e-05	0.000203	CcSEcCtD
Riluzole—Body temperature increased—Paclitaxel—lung cancer	3.18e-05	0.000203	CcSEcCtD
Riluzole—Hepatobiliary disease—Doxorubicin—lung cancer	3.15e-05	0.000202	CcSEcCtD
Riluzole—Epistaxis—Doxorubicin—lung cancer	3.14e-05	0.000201	CcSEcCtD
Riluzole—Angiopathy—Methotrexate—lung cancer	3.13e-05	0.0002	CcSEcCtD
Riluzole—Vomiting—Irinotecan—lung cancer	3.13e-05	0.0002	CcSEcCtD
Riluzole—Sinusitis—Doxorubicin—lung cancer	3.13e-05	0.0002	CcSEcCtD
Riluzole—Immune system disorder—Methotrexate—lung cancer	3.12e-05	0.0002	CcSEcCtD
Riluzole—Mediastinal disorder—Methotrexate—lung cancer	3.11e-05	0.000199	CcSEcCtD
Riluzole—Agranulocytosis—Doxorubicin—lung cancer	3.11e-05	0.000199	CcSEcCtD
Riluzole—Rash—Irinotecan—lung cancer	3.11e-05	0.000199	CcSEcCtD
Riluzole—Dermatitis—Irinotecan—lung cancer	3.1e-05	0.000198	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Docetaxel—lung cancer	3.1e-05	0.000198	CcSEcCtD
Riluzole—Chills—Methotrexate—lung cancer	3.1e-05	0.000198	CcSEcCtD
Riluzole—Headache—Irinotecan—lung cancer	3.09e-05	0.000197	CcSEcCtD
Riluzole—Insomnia—Docetaxel—lung cancer	3.08e-05	0.000197	CcSEcCtD
Riluzole—Diarrhoea—Cisplatin—lung cancer	3.06e-05	0.000196	CcSEcCtD
Riluzole—Paraesthesia—Docetaxel—lung cancer	3.06e-05	0.000196	CcSEcCtD
Riluzole—Alopecia—Methotrexate—lung cancer	3.05e-05	0.000195	CcSEcCtD
Riluzole—Vomiting—Gemcitabine—lung cancer	3.05e-05	0.000195	CcSEcCtD
Riluzole—Bradycardia—Doxorubicin—lung cancer	3.04e-05	0.000195	CcSEcCtD
Riluzole—Dyspnoea—Docetaxel—lung cancer	3.04e-05	0.000194	CcSEcCtD
Riluzole—Somnolence—Docetaxel—lung cancer	3.03e-05	0.000194	CcSEcCtD
Riluzole—Mental disorder—Methotrexate—lung cancer	3.03e-05	0.000194	CcSEcCtD
Riluzole—Rash—Gemcitabine—lung cancer	3.02e-05	0.000193	CcSEcCtD
Riluzole—Dermatitis—Gemcitabine—lung cancer	3.02e-05	0.000193	CcSEcCtD
Riluzole—Hypersensitivity—Etoposide—lung cancer	3.02e-05	0.000193	CcSEcCtD
Riluzole—Malnutrition—Methotrexate—lung cancer	3.01e-05	0.000192	CcSEcCtD
Riluzole—Haemoglobin—Doxorubicin—lung cancer	3.01e-05	0.000192	CcSEcCtD
Riluzole—Headache—Gemcitabine—lung cancer	3.01e-05	0.000192	CcSEcCtD
Riluzole—Rhinitis—Doxorubicin—lung cancer	3e-05	0.000192	CcSEcCtD
Riluzole—Dyspepsia—Docetaxel—lung cancer	3e-05	0.000192	CcSEcCtD
Riluzole—Haemorrhage—Doxorubicin—lung cancer	2.99e-05	0.000191	CcSEcCtD
Riluzole—Hepatitis—Doxorubicin—lung cancer	2.99e-05	0.000191	CcSEcCtD
Riluzole—Hypoaesthesia—Doxorubicin—lung cancer	2.98e-05	0.00019	CcSEcCtD
Riluzole—Pharyngitis—Doxorubicin—lung cancer	2.97e-05	0.00019	CcSEcCtD
Riluzole—Decreased appetite—Docetaxel—lung cancer	2.96e-05	0.000189	CcSEcCtD
Riluzole—Hypersensitivity—Paclitaxel—lung cancer	2.96e-05	0.000189	CcSEcCtD
Riluzole—Urinary tract disorder—Doxorubicin—lung cancer	2.95e-05	0.000189	CcSEcCtD
Riluzole—Oedema peripheral—Doxorubicin—lung cancer	2.95e-05	0.000188	CcSEcCtD
Riluzole—Dysgeusia—Methotrexate—lung cancer	2.94e-05	0.000188	CcSEcCtD
Riluzole—Gastrointestinal disorder—Docetaxel—lung cancer	2.94e-05	0.000188	CcSEcCtD
Riluzole—Asthenia—Etoposide—lung cancer	2.94e-05	0.000188	CcSEcCtD
Riluzole—Connective tissue disorder—Doxorubicin—lung cancer	2.94e-05	0.000188	CcSEcCtD
Riluzole—Fatigue—Docetaxel—lung cancer	2.94e-05	0.000188	CcSEcCtD
Riluzole—Urethral disorder—Doxorubicin—lung cancer	2.93e-05	0.000187	CcSEcCtD
Riluzole—Nausea—Irinotecan—lung cancer	2.93e-05	0.000187	CcSEcCtD
Riluzole—Constipation—Docetaxel—lung cancer	2.91e-05	0.000186	CcSEcCtD
Riluzole—Pain—Docetaxel—lung cancer	2.91e-05	0.000186	CcSEcCtD
Riluzole—Back pain—Methotrexate—lung cancer	2.91e-05	0.000186	CcSEcCtD
Riluzole—Pruritus—Etoposide—lung cancer	2.9e-05	0.000185	CcSEcCtD
Riluzole—Asthenia—Paclitaxel—lung cancer	2.88e-05	0.000184	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	2.86e-05	0.000436	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL6—lung cancer	2.86e-05	0.000436	CbGpPWpGaD
Riluzole—Nausea—Gemcitabine—lung cancer	2.85e-05	0.000182	CcSEcCtD
Riluzole—Vomiting—Cisplatin—lung cancer	2.84e-05	0.000182	CcSEcCtD
Riluzole—Pruritus—Paclitaxel—lung cancer	2.84e-05	0.000182	CcSEcCtD
Riluzole—Erythema multiforme—Doxorubicin—lung cancer	2.83e-05	0.000181	CcSEcCtD
Riluzole—ABCG2—Metabolism—CKB—lung cancer	2.83e-05	0.000431	CbGpPWpGaD
Riluzole—Rash—Cisplatin—lung cancer	2.82e-05	0.00018	CcSEcCtD
Riluzole—Dermatitis—Cisplatin—lung cancer	2.82e-05	0.00018	CcSEcCtD
Riluzole—Feeling abnormal—Docetaxel—lung cancer	2.81e-05	0.000179	CcSEcCtD
Riluzole—Diarrhoea—Etoposide—lung cancer	2.8e-05	0.000179	CcSEcCtD
Riluzole—Eye disorder—Doxorubicin—lung cancer	2.79e-05	0.000179	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—SRC—lung cancer	2.79e-05	0.000426	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—lung cancer	2.79e-05	0.000426	CbGpPWpGaD
Riluzole—Ill-defined disorder—Methotrexate—lung cancer	2.79e-05	0.000178	CcSEcCtD
Riluzole—Gastrointestinal pain—Docetaxel—lung cancer	2.78e-05	0.000178	CcSEcCtD
Riluzole—Anaemia—Methotrexate—lung cancer	2.78e-05	0.000178	CcSEcCtD
Riluzole—Cardiac disorder—Doxorubicin—lung cancer	2.78e-05	0.000178	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	2.77e-05	0.000422	CbGpPWpGaD
Riluzole—Diarrhoea—Paclitaxel—lung cancer	2.75e-05	0.000176	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—VEGFA—lung cancer	2.72e-05	0.000415	CbGpPWpGaD
Riluzole—Angiopathy—Doxorubicin—lung cancer	2.71e-05	0.000174	CcSEcCtD
Riluzole—Malaise—Methotrexate—lung cancer	2.71e-05	0.000173	CcSEcCtD
Riluzole—Dizziness—Etoposide—lung cancer	2.71e-05	0.000173	CcSEcCtD
Riluzole—Immune system disorder—Doxorubicin—lung cancer	2.7e-05	0.000173	CcSEcCtD
Riluzole—Vertigo—Methotrexate—lung cancer	2.7e-05	0.000173	CcSEcCtD
Riluzole—Mediastinal disorder—Doxorubicin—lung cancer	2.7e-05	0.000172	CcSEcCtD
Riluzole—Body temperature increased—Docetaxel—lung cancer	2.69e-05	0.000172	CcSEcCtD
Riluzole—Abdominal pain—Docetaxel—lung cancer	2.69e-05	0.000172	CcSEcCtD
Riluzole—Leukopenia—Methotrexate—lung cancer	2.69e-05	0.000172	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—NRAS—lung cancer	2.69e-05	0.00041	CbGpPWpGaD
Riluzole—Chills—Doxorubicin—lung cancer	2.68e-05	0.000172	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	2.68e-05	0.000409	CbGpPWpGaD
Riluzole—Arrhythmia—Doxorubicin—lung cancer	2.67e-05	0.000171	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	2.66e-05	0.000406	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CNDP2—lung cancer	2.66e-05	0.000405	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTM2—lung cancer	2.66e-05	0.000405	CbGpPWpGaD
Riluzole—Dizziness—Paclitaxel—lung cancer	2.66e-05	0.00017	CcSEcCtD
Riluzole—Nausea—Cisplatin—lung cancer	2.66e-05	0.00017	CcSEcCtD
Riluzole—Alopecia—Doxorubicin—lung cancer	2.64e-05	0.000169	CcSEcCtD
Riluzole—Cough—Methotrexate—lung cancer	2.62e-05	0.000168	CcSEcCtD
Riluzole—Mental disorder—Doxorubicin—lung cancer	2.62e-05	0.000168	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	2.61e-05	0.000397	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	2.61e-05	0.000397	CbGpPWpGaD
Riluzole—Convulsion—Methotrexate—lung cancer	2.61e-05	0.000167	CcSEcCtD
Riluzole—Vomiting—Etoposide—lung cancer	2.6e-05	0.000167	CcSEcCtD
Riluzole—Malnutrition—Doxorubicin—lung cancer	2.6e-05	0.000166	CcSEcCtD
Riluzole—ABCG2—Metabolism—MTMR3—lung cancer	2.58e-05	0.000394	CbGpPWpGaD
Riluzole—Rash—Etoposide—lung cancer	2.58e-05	0.000165	CcSEcCtD
Riluzole—Dermatitis—Etoposide—lung cancer	2.58e-05	0.000165	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—MAPK3—lung cancer	2.57e-05	0.000392	CbGpPWpGaD
Riluzole—Headache—Etoposide—lung cancer	2.57e-05	0.000164	CcSEcCtD
Riluzole—Flatulence—Doxorubicin—lung cancer	2.57e-05	0.000164	CcSEcCtD
Riluzole—SCN5A—Axon guidance—MMP9—lung cancer	2.56e-05	0.000391	CbGpPWpGaD
Riluzole—Myalgia—Methotrexate—lung cancer	2.56e-05	0.000164	CcSEcCtD
Riluzole—Arthralgia—Methotrexate—lung cancer	2.56e-05	0.000164	CcSEcCtD
Riluzole—Chest pain—Methotrexate—lung cancer	2.56e-05	0.000164	CcSEcCtD
Riluzole—Tension—Doxorubicin—lung cancer	2.55e-05	0.000163	CcSEcCtD
Riluzole—Vomiting—Paclitaxel—lung cancer	2.55e-05	0.000163	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—IL6R—lung cancer	2.55e-05	0.000389	CbGpPWpGaD
Riluzole—Dysgeusia—Doxorubicin—lung cancer	2.55e-05	0.000163	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—CREBBP—lung cancer	2.55e-05	0.000388	CbGpPWpGaD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.54e-05	0.000163	CcSEcCtD
Riluzole—Rash—Paclitaxel—lung cancer	2.53e-05	0.000162	CcSEcCtD
Riluzole—Dermatitis—Paclitaxel—lung cancer	2.53e-05	0.000162	CcSEcCtD
Riluzole—Discomfort—Methotrexate—lung cancer	2.53e-05	0.000162	CcSEcCtD
Riluzole—Nervousness—Doxorubicin—lung cancer	2.53e-05	0.000162	CcSEcCtD
Riluzole—CYP1A1—Metabolism—ATP5H—lung cancer	2.52e-05	0.000385	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PGAM1—lung cancer	2.52e-05	0.000384	CbGpPWpGaD
Riluzole—Back pain—Doxorubicin—lung cancer	2.52e-05	0.000161	CcSEcCtD
Riluzole—Headache—Paclitaxel—lung cancer	2.52e-05	0.000161	CcSEcCtD
Riluzole—CYP1A1—Biological oxidations—POMC—lung cancer	2.52e-05	0.000384	CbGpPWpGaD
Riluzole—Hypersensitivity—Docetaxel—lung cancer	2.51e-05	0.00016	CcSEcCtD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	2.5e-05	0.000382	CbGpPWpGaD
Riluzole—Muscle spasms—Doxorubicin—lung cancer	2.5e-05	0.00016	CcSEcCtD
Riluzole—Confusional state—Methotrexate—lung cancer	2.47e-05	0.000158	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—GSTP1—lung cancer	2.47e-05	0.000377	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	2.46e-05	0.000375	CbGpPWpGaD
Riluzole—Anaphylactic shock—Methotrexate—lung cancer	2.45e-05	0.000157	CcSEcCtD
Riluzole—Asthenia—Docetaxel—lung cancer	2.44e-05	0.000156	CcSEcCtD
Riluzole—Infection—Methotrexate—lung cancer	2.44e-05	0.000156	CcSEcCtD
Riluzole—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	2.44e-05	0.000371	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP2—lung cancer	2.43e-05	0.000371	CbGpPWpGaD
Riluzole—Nausea—Etoposide—lung cancer	2.43e-05	0.000156	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—MAP2K1—lung cancer	2.43e-05	0.000371	CbGpPWpGaD
Riluzole—Ill-defined disorder—Doxorubicin—lung cancer	2.42e-05	0.000154	CcSEcCtD
Riluzole—Pruritus—Docetaxel—lung cancer	2.41e-05	0.000154	CcSEcCtD
Riluzole—Nervous system disorder—Methotrexate—lung cancer	2.41e-05	0.000154	CcSEcCtD
Riluzole—Anaemia—Doxorubicin—lung cancer	2.41e-05	0.000154	CcSEcCtD
Riluzole—ABCG2—Metabolism—CYP2A7—lung cancer	2.4e-05	0.000366	CbGpPWpGaD
Riluzole—Thrombocytopenia—Methotrexate—lung cancer	2.4e-05	0.000154	CcSEcCtD
Riluzole—Agitation—Doxorubicin—lung cancer	2.39e-05	0.000153	CcSEcCtD
Riluzole—CYP1A1—PPARA activates gene expression—EP300—lung cancer	2.39e-05	0.000364	CbGpPWpGaD
Riluzole—Nausea—Paclitaxel—lung cancer	2.39e-05	0.000153	CcSEcCtD
Riluzole—Skin disorder—Methotrexate—lung cancer	2.38e-05	0.000152	CcSEcCtD
Riluzole—Hyperhidrosis—Methotrexate—lung cancer	2.37e-05	0.000152	CcSEcCtD
Riluzole—SCN5A—Axon guidance—SRC—lung cancer	2.36e-05	0.00036	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—lung cancer	2.36e-05	0.00036	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SDC4—lung cancer	2.35e-05	0.000359	CbGpPWpGaD
Riluzole—Malaise—Doxorubicin—lung cancer	2.35e-05	0.00015	CcSEcCtD
Riluzole—Vertigo—Doxorubicin—lung cancer	2.34e-05	0.00015	CcSEcCtD
Riluzole—Anorexia—Methotrexate—lung cancer	2.34e-05	0.00015	CcSEcCtD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—lung cancer	2.34e-05	0.000356	CbGpPWpGaD
Riluzole—Syncope—Doxorubicin—lung cancer	2.33e-05	0.000149	CcSEcCtD
Riluzole—Leukopenia—Doxorubicin—lung cancer	2.33e-05	0.000149	CcSEcCtD
Riluzole—Diarrhoea—Docetaxel—lung cancer	2.33e-05	0.000149	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	2.32e-05	0.000354	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—KRAS—lung cancer	2.31e-05	0.000353	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—VEGFA—lung cancer	2.3e-05	0.000351	CbGpPWpGaD
Riluzole—Palpitations—Doxorubicin—lung cancer	2.3e-05	0.000147	CcSEcCtD
Riluzole—Hypotension—Methotrexate—lung cancer	2.29e-05	0.000147	CcSEcCtD
Riluzole—Loss of consciousness—Doxorubicin—lung cancer	2.29e-05	0.000146	CcSEcCtD
Riluzole—SCN5A—Axon guidance—NRAS—lung cancer	2.27e-05	0.000347	CbGpPWpGaD
Riluzole—Cough—Doxorubicin—lung cancer	2.27e-05	0.000145	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—GSTM1—lung cancer	2.27e-05	0.000346	CbGpPWpGaD
Riluzole—Convulsion—Doxorubicin—lung cancer	2.26e-05	0.000144	CcSEcCtD
Riluzole—Dizziness—Docetaxel—lung cancer	2.25e-05	0.000144	CcSEcCtD
Riluzole—CYP1A1—Metabolism—PLBD1—lung cancer	2.25e-05	0.000343	CbGpPWpGaD
Riluzole—Hypertension—Doxorubicin—lung cancer	2.25e-05	0.000144	CcSEcCtD
Riluzole—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	2.24e-05	0.000341	CbGpPWpGaD
Riluzole—Musculoskeletal discomfort—Methotrexate—lung cancer	2.24e-05	0.000143	CcSEcCtD
Riluzole—Insomnia—Methotrexate—lung cancer	2.22e-05	0.000142	CcSEcCtD
Riluzole—Myalgia—Doxorubicin—lung cancer	2.22e-05	0.000142	CcSEcCtD
Riluzole—Chest pain—Doxorubicin—lung cancer	2.22e-05	0.000142	CcSEcCtD
Riluzole—Arthralgia—Doxorubicin—lung cancer	2.22e-05	0.000142	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.21e-05	0.000337	CbGpPWpGaD
Riluzole—Anxiety—Doxorubicin—lung cancer	2.21e-05	0.000141	CcSEcCtD
Riluzole—Paraesthesia—Methotrexate—lung cancer	2.2e-05	0.000141	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.2e-05	0.000141	CcSEcCtD
Riluzole—Discomfort—Doxorubicin—lung cancer	2.19e-05	0.00014	CcSEcCtD
Riluzole—Dyspnoea—Methotrexate—lung cancer	2.19e-05	0.00014	CcSEcCtD
Riluzole—Somnolence—Methotrexate—lung cancer	2.18e-05	0.00014	CcSEcCtD
Riluzole—SCN5A—Axon guidance—MAPK3—lung cancer	2.18e-05	0.000332	CbGpPWpGaD
Riluzole—Dry mouth—Doxorubicin—lung cancer	2.17e-05	0.000139	CcSEcCtD
Riluzole—Vomiting—Docetaxel—lung cancer	2.16e-05	0.000138	CcSEcCtD
Riluzole—Dyspepsia—Methotrexate—lung cancer	2.16e-05	0.000138	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—RAF1—lung cancer	2.16e-05	0.000329	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP1A1—lung cancer	2.15e-05	0.000328	CbGpPWpGaD
Riluzole—Rash—Docetaxel—lung cancer	2.15e-05	0.000137	CcSEcCtD
Riluzole—Dermatitis—Docetaxel—lung cancer	2.14e-05	0.000137	CcSEcCtD
Riluzole—Confusional state—Doxorubicin—lung cancer	2.14e-05	0.000137	CcSEcCtD
Riluzole—ABCG2—Metabolism—RRM1—lung cancer	2.14e-05	0.000327	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTA3—lung cancer	2.14e-05	0.000327	CbGpPWpGaD
Riluzole—Decreased appetite—Methotrexate—lung cancer	2.13e-05	0.000136	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—ERBB2—lung cancer	2.13e-05	0.000325	CbGpPWpGaD
Riluzole—Headache—Docetaxel—lung cancer	2.13e-05	0.000136	CcSEcCtD
Riluzole—Oedema—Doxorubicin—lung cancer	2.12e-05	0.000136	CcSEcCtD
Riluzole—Anaphylactic shock—Doxorubicin—lung cancer	2.12e-05	0.000136	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—PIK3CA—lung cancer	2.12e-05	0.000324	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	2.12e-05	0.000324	CbGpPWpGaD
Riluzole—Gastrointestinal disorder—Methotrexate—lung cancer	2.12e-05	0.000135	CcSEcCtD
Riluzole—Fatigue—Methotrexate—lung cancer	2.12e-05	0.000135	CcSEcCtD
Riluzole—Infection—Doxorubicin—lung cancer	2.11e-05	0.000135	CcSEcCtD
Riluzole—Pain—Methotrexate—lung cancer	2.1e-05	0.000134	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	2.09e-05	0.000319	CbGpPWpGaD
Riluzole—Shock—Doxorubicin—lung cancer	2.09e-05	0.000134	CcSEcCtD
Riluzole—Nervous system disorder—Doxorubicin—lung cancer	2.08e-05	0.000133	CcSEcCtD
Riluzole—Thrombocytopenia—Doxorubicin—lung cancer	2.08e-05	0.000133	CcSEcCtD
Riluzole—Tachycardia—Doxorubicin—lung cancer	2.07e-05	0.000133	CcSEcCtD
Riluzole—SCN5A—Axon guidance—EGFR—lung cancer	2.07e-05	0.000316	CbGpPWpGaD
Riluzole—Skin disorder—Doxorubicin—lung cancer	2.06e-05	0.000132	CcSEcCtD
Riluzole—CYP1A1—Metabolism—HSD17B10—lung cancer	2.06e-05	0.000314	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TP53—lung cancer	2.06e-05	0.000313	CbGpPWpGaD
Riluzole—Hyperhidrosis—Doxorubicin—lung cancer	2.05e-05	0.000131	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—AVP—lung cancer	2.04e-05	0.000311	CbGpPWpGaD
Riluzole—Anorexia—Doxorubicin—lung cancer	2.03e-05	0.00013	CcSEcCtD
Riluzole—Nausea—Docetaxel—lung cancer	2.02e-05	0.000129	CcSEcCtD
Riluzole—Feeling abnormal—Methotrexate—lung cancer	2.02e-05	0.000129	CcSEcCtD
Riluzole—ABCG2—Metabolism—B4GALT5—lung cancer	2.01e-05	0.000307	CbGpPWpGaD
Riluzole—Gastrointestinal pain—Methotrexate—lung cancer	2.01e-05	0.000128	CcSEcCtD
Riluzole—Hypotension—Doxorubicin—lung cancer	1.99e-05	0.000127	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—ABCB1—lung cancer	1.98e-05	0.000302	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—HRAS—lung cancer	1.97e-05	0.0003	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTA4—lung cancer	1.96e-05	0.000299	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—KRAS—lung cancer	1.96e-05	0.000298	CbGpPWpGaD
Riluzole—Urticaria—Methotrexate—lung cancer	1.95e-05	0.000125	CcSEcCtD
Riluzole—Body temperature increased—Methotrexate—lung cancer	1.94e-05	0.000124	CcSEcCtD
Riluzole—Abdominal pain—Methotrexate—lung cancer	1.94e-05	0.000124	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.94e-05	0.000124	CcSEcCtD
Riluzole—Insomnia—Doxorubicin—lung cancer	1.92e-05	0.000123	CcSEcCtD
Riluzole—CYP1A1—Metabolism—CKB—lung cancer	1.91e-05	0.000292	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTA2—lung cancer	1.91e-05	0.000291	CbGpPWpGaD
Riluzole—Paraesthesia—Doxorubicin—lung cancer	1.91e-05	0.000122	CcSEcCtD
Riluzole—Dyspnoea—Doxorubicin—lung cancer	1.89e-05	0.000121	CcSEcCtD
Riluzole—CYP1A2—Metabolism—COL4A3BP—lung cancer	1.89e-05	0.000289	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AZIN2—lung cancer	1.89e-05	0.000289	CbGpPWpGaD
Riluzole—Somnolence—Doxorubicin—lung cancer	1.89e-05	0.000121	CcSEcCtD
Riluzole—Dyspepsia—Doxorubicin—lung cancer	1.87e-05	0.00012	CcSEcCtD
Riluzole—Decreased appetite—Doxorubicin—lung cancer	1.85e-05	0.000118	CcSEcCtD
Riluzole—ABCG2—Metabolism—GSTA1—lung cancer	1.84e-05	0.000281	CbGpPWpGaD
Riluzole—Gastrointestinal disorder—Doxorubicin—lung cancer	1.83e-05	0.000117	CcSEcCtD
Riluzole—Fatigue—Doxorubicin—lung cancer	1.83e-05	0.000117	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—MMP9—lung cancer	1.83e-05	0.000279	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCC3—lung cancer	1.82e-05	0.000278	CbGpPWpGaD
Riluzole—Constipation—Doxorubicin—lung cancer	1.82e-05	0.000116	CcSEcCtD
Riluzole—Pain—Doxorubicin—lung cancer	1.82e-05	0.000116	CcSEcCtD
Riluzole—Hypersensitivity—Methotrexate—lung cancer	1.81e-05	0.000116	CcSEcCtD
Riluzole—CYP1A1—Metabolism—GSTM2—lung cancer	1.8e-05	0.000274	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CNDP2—lung cancer	1.8e-05	0.000274	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	1.76e-05	0.000269	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AKR1C1—lung cancer	1.76e-05	0.000269	CbGpPWpGaD
Riluzole—Asthenia—Methotrexate—lung cancer	1.76e-05	0.000113	CcSEcCtD
Riluzole—Feeling abnormal—Doxorubicin—lung cancer	1.75e-05	0.000112	CcSEcCtD
Riluzole—CYP1A1—Metabolism—MTMR3—lung cancer	1.75e-05	0.000267	CbGpPWpGaD
Riluzole—Gastrointestinal pain—Doxorubicin—lung cancer	1.74e-05	0.000111	CcSEcCtD
Riluzole—Pruritus—Methotrexate—lung cancer	1.74e-05	0.000111	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—AKT1—lung cancer	1.74e-05	0.000265	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—EP300—lung cancer	1.73e-05	0.000264	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—UGT1A1—lung cancer	1.71e-05	0.000261	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	1.71e-05	0.000261	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PGAM1—lung cancer	1.7e-05	0.00026	CbGpPWpGaD
Riluzole—Urticaria—Doxorubicin—lung cancer	1.69e-05	0.000108	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—SRC—lung cancer	1.69e-05	0.000257	CbGpPWpGaD
Riluzole—Abdominal pain—Doxorubicin—lung cancer	1.68e-05	0.000107	CcSEcCtD
Riluzole—Body temperature increased—Doxorubicin—lung cancer	1.68e-05	0.000107	CcSEcCtD
Riluzole—Diarrhoea—Methotrexate—lung cancer	1.68e-05	0.000107	CcSEcCtD
Riluzole—SCN5A—Axon guidance—HRAS—lung cancer	1.66e-05	0.000254	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GNG11—lung cancer	1.65e-05	0.000252	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—VEGFA—lung cancer	1.64e-05	0.00025	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—STAT3—lung cancer	1.63e-05	0.000248	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2A7—lung cancer	1.63e-05	0.000248	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—NRAS—lung cancer	1.62e-05	0.000247	CbGpPWpGaD
Riluzole—Dizziness—Methotrexate—lung cancer	1.62e-05	0.000104	CcSEcCtD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—lung cancer	1.61e-05	0.000245	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ATP5H—lung cancer	1.61e-05	0.000245	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—POMC—lung cancer	1.6e-05	0.000245	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—IL6—lung cancer	1.59e-05	0.000243	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SDC4—lung cancer	1.59e-05	0.000243	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALDOA—lung cancer	1.57e-05	0.00024	CbGpPWpGaD
Riluzole—Hypersensitivity—Doxorubicin—lung cancer	1.57e-05	0.0001	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—APOA1—lung cancer	1.56e-05	0.000238	CbGpPWpGaD
Riluzole—Vomiting—Methotrexate—lung cancer	1.56e-05	9.98e-05	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—MAPK3—lung cancer	1.55e-05	0.000237	CbGpPWpGaD
Riluzole—Rash—Methotrexate—lung cancer	1.55e-05	9.89e-05	CcSEcCtD
Riluzole—Dermatitis—Methotrexate—lung cancer	1.55e-05	9.89e-05	CcSEcCtD
Riluzole—Headache—Methotrexate—lung cancer	1.54e-05	9.83e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—NCOA3—lung cancer	1.53e-05	0.000233	CbGpPWpGaD
Riluzole—Asthenia—Doxorubicin—lung cancer	1.52e-05	9.75e-05	CcSEcCtD
Riluzole—Pruritus—Doxorubicin—lung cancer	1.5e-05	9.61e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—ADCY1—lung cancer	1.48e-05	0.000226	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	1.48e-05	0.000225	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—EGFR—lung cancer	1.48e-05	0.000225	CbGpPWpGaD
Riluzole—Nausea—Methotrexate—lung cancer	1.46e-05	9.32e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—ENO2—lung cancer	1.46e-05	0.000222	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HPGDS—lung cancer	1.46e-05	0.000222	CbGpPWpGaD
Riluzole—Diarrhoea—Doxorubicin—lung cancer	1.45e-05	9.3e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—GSTA3—lung cancer	1.45e-05	0.000221	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—RRM1—lung cancer	1.45e-05	0.000221	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPP2R1B—lung cancer	1.45e-05	0.000221	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PLBD1—lung cancer	1.43e-05	0.000219	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTT1—lung cancer	1.41e-05	0.000215	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	1.41e-05	0.000215	CbGpPWpGaD
Riluzole—Dizziness—Doxorubicin—lung cancer	1.41e-05	8.99e-05	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—KRAS—lung cancer	1.4e-05	0.000213	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GCLC—lung cancer	1.4e-05	0.000213	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP2A6—lung cancer	1.4e-05	0.000213	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—B4GALT5—lung cancer	1.36e-05	0.000208	CbGpPWpGaD
Riluzole—Vomiting—Doxorubicin—lung cancer	1.35e-05	8.64e-05	CcSEcCtD
Riluzole—Rash—Doxorubicin—lung cancer	1.34e-05	8.57e-05	CcSEcCtD
Riluzole—Dermatitis—Doxorubicin—lung cancer	1.34e-05	8.56e-05	CcSEcCtD
Riluzole—Headache—Doxorubicin—lung cancer	1.33e-05	8.51e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—GSTA4—lung cancer	1.33e-05	0.000202	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ENO1—lung cancer	1.32e-05	0.000202	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—CREBBP—lung cancer	1.32e-05	0.000202	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HSD17B10—lung cancer	1.31e-05	0.0002	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTA2—lung cancer	1.29e-05	0.000197	CbGpPWpGaD
Riluzole—Nausea—Doxorubicin—lung cancer	1.26e-05	8.07e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—GSTA1—lung cancer	1.25e-05	0.00019	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ALB—lung cancer	1.24e-05	0.000189	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCC3—lung cancer	1.23e-05	0.000188	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CKB—lung cancer	1.22e-05	0.000186	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AKR1C1—lung cancer	1.19e-05	0.000182	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HRAS—lung cancer	1.19e-05	0.000181	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP2E1—lung cancer	1.19e-05	0.000181	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NQO1—lung cancer	1.17e-05	0.000179	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—UGT1A1—lung cancer	1.16e-05	0.000177	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTM2—lung cancer	1.15e-05	0.000175	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CNDP2—lung cancer	1.15e-05	0.000175	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—IL6—lung cancer	1.14e-05	0.000173	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—RAF1—lung cancer	1.12e-05	0.000171	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GNG11—lung cancer	1.12e-05	0.00017	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MTMR3—lung cancer	1.12e-05	0.00017	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.11e-05	0.00017	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PGAM1—lung cancer	1.09e-05	0.000166	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALDOA—lung cancer	1.06e-05	0.000162	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—STK11—lung cancer	1.06e-05	0.000161	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—AKT1—lung cancer	1.05e-05	0.00016	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2A7—lung cancer	1.04e-05	0.000158	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NCOA3—lung cancer	1.03e-05	0.000157	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.02e-05	0.000155	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SDC4—lung cancer	1.01e-05	0.000155	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ADCY1—lung cancer	1e-05	0.000153	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCG2—lung cancer	1e-05	0.000153	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HPGDS—lung cancer	9.85e-06	0.00015	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ENO2—lung cancer	9.85e-06	0.00015	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPP2R1B—lung cancer	9.79e-06	0.000149	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTP1—lung cancer	9.79e-06	0.000149	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.66e-06	0.000147	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTT1—lung cancer	9.56e-06	0.000146	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CAT—lung cancer	9.52e-06	0.000145	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GCLC—lung cancer	9.45e-06	0.000144	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2A6—lung cancer	9.45e-06	0.000144	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.41e-06	0.000143	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCB1—lung cancer	9.26e-06	0.000141	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—RRM1—lung cancer	9.24e-06	0.000141	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA3—lung cancer	9.24e-06	0.000141	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TYMS—lung cancer	9.1e-06	0.000139	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTM1—lung cancer	8.99e-06	0.000137	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ENO1—lung cancer	8.96e-06	0.000137	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.92e-06	0.000136	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.81e-06	0.000134	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—B4GALT5—lung cancer	8.69e-06	0.000133	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP1A1—lung cancer	8.53e-06	0.00013	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ERCC2—lung cancer	8.46e-06	0.000129	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA4—lung cancer	8.45e-06	0.000129	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	8.26e-06	0.000126	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA2—lung cancer	8.24e-06	0.000126	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2E1—lung cancer	8.03e-06	0.000122	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA1—lung cancer	7.95e-06	0.000121	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NQO1—lung cancer	7.94e-06	0.000121	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCC3—lung cancer	7.86e-06	0.00012	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.78e-06	0.000119	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.71e-06	0.000117	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AKR1C1—lung cancer	7.61e-06	0.000116	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—UGT1A1—lung cancer	7.39e-06	0.000113	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOA1—lung cancer	7.32e-06	0.000112	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—STK11—lung cancer	7.16e-06	0.000109	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GNG11—lung cancer	7.13e-06	0.000109	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	7.09e-06	0.000108	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALDOA—lung cancer	6.78e-06	0.000103	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.72e-06	0.000102	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CG—lung cancer	6.68e-06	0.000102	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTP1—lung cancer	6.62e-06	0.000101	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NCOA3—lung cancer	6.59e-06	0.0001	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.47e-06	9.87e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CAT—lung cancer	6.45e-06	9.83e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.41e-06	9.77e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ADCY1—lung cancer	6.41e-06	9.77e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCG2—lung cancer	6.41e-06	9.77e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—POMC—lung cancer	6.36e-06	9.69e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HPGDS—lung cancer	6.28e-06	9.58e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ENO2—lung cancer	6.28e-06	9.58e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCB1—lung cancer	6.27e-06	9.56e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPP2R1B—lung cancer	6.24e-06	9.52e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CREBBP—lung cancer	6.19e-06	9.44e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.16e-06	9.39e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TYMS—lung cancer	6.16e-06	9.39e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTT1—lung cancer	6.09e-06	9.29e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTM1—lung cancer	6.09e-06	9.28e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GCLC—lung cancer	6.02e-06	9.18e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2A6—lung cancer	6.02e-06	9.18e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6e-06	9.15e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CD—lung cancer	5.87e-06	8.95e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALB—lung cancer	5.8e-06	8.84e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ERCC2—lung cancer	5.72e-06	8.73e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ENO1—lung cancer	5.71e-06	8.71e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.69e-06	8.67e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.62e-06	8.56e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2E1—lung cancer	5.12e-06	7.81e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CB—lung cancer	5.12e-06	7.8e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS2—lung cancer	5.07e-06	7.73e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NQO1—lung cancer	5.06e-06	7.72e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.96e-06	7.56e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOA1—lung cancer	4.95e-06	7.55e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.91e-06	7.49e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.74e-06	7.23e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—STK11—lung cancer	4.57e-06	6.96e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CG—lung cancer	4.52e-06	6.89e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTEN—lung cancer	4.42e-06	6.74e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—POMC—lung cancer	4.3e-06	6.56e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.29e-06	6.53e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTP1—lung cancer	4.22e-06	6.44e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—EP300—lung cancer	4.22e-06	6.43e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CREBBP—lung cancer	4.19e-06	6.39e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CAT—lung cancer	4.11e-06	6.27e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.09e-06	6.23e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCB1—lung cancer	4e-06	6.1e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CD—lung cancer	3.97e-06	6.06e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TYMS—lung cancer	3.93e-06	5.99e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALB—lung cancer	3.92e-06	5.98e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTM1—lung cancer	3.88e-06	5.92e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP1A1—lung cancer	3.68e-06	5.61e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ERCC2—lung cancer	3.65e-06	5.56e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CB—lung cancer	3.46e-06	5.28e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS2—lung cancer	3.43e-06	5.23e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOA1—lung cancer	3.16e-06	4.81e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CA—lung cancer	3.12e-06	4.76e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.02e-06	4.61e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTEN—lung cancer	2.99e-06	4.56e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CG—lung cancer	2.88e-06	4.39e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—EP300—lung cancer	2.85e-06	4.35e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—POMC—lung cancer	2.74e-06	4.18e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CREBBP—lung cancer	2.67e-06	4.07e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AKT1—lung cancer	2.55e-06	3.89e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CD—lung cancer	2.53e-06	3.86e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALB—lung cancer	2.5e-06	3.81e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CB—lung cancer	2.21e-06	3.37e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS2—lung cancer	2.19e-06	3.34e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CA—lung cancer	2.11e-06	3.22e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTEN—lung cancer	1.91e-06	2.91e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—EP300—lung cancer	1.82e-06	2.77e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AKT1—lung cancer	1.73e-06	2.63e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CA—lung cancer	1.35e-06	2.05e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AKT1—lung cancer	1.1e-06	1.68e-05	CbGpPWpGaD
